Filing Details

Accession Number:
0001209191-23-021136
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-24 19:18:57
Reporting Period:
2023-03-24
Accepted Time:
2023-03-24 19:18:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1582313 Xenon Pharmaceuticals Inc. XENE Pharmaceutical Preparations (2834) 980661854
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1880129 John Christopher Kenney 200 - 3650 Gilmore Way
Burnaby A1 V5G 4W8
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2023-03-24 700 $35.01 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct